Samtidig administration af laropiprant 40 mg og midazolam øgede AUC0- ∞ og Cmax for 1 '- hydroxymidazolam, en midazolammetabolit, med henholdsvis 98% og 59%.
Co-administration of laropiprant 40 mg with midazolam increased the AUC0-∞ and Cmax of 1'-hydroxymidazolam, a midazolam metabolite, by 98% and 59%, respectively.